Core Viewpoint - The company, Bawang Chaji, faced significant stock price volatility due to public concerns regarding caffeine content in its products, prompting a detailed response to clarify the situation and defend its reputation [1][2]. Group 1: Stock Performance - On December 26, Bawang Chaji's stock price dropped over 14%, reaching an all-time low since its IPO, before closing down 2.54% [1]. - The company went public on NASDAQ on April 17, becoming the first new-style tea brand to list on the US market [2]. Group 2: Caffeine Controversy - Bawang Chaji addressed concerns about caffeine levels in its tea, stating that the caffeine content in its brewed tea is comparable to that of a latte and significantly lower than that of an Americano [1]. - The company emphasized that caffeine is a natural component of tea and is not artificially added, maintaining a commitment to using whole leaf tea for a richer flavor [1]. Group 3: Legal Action and Business Performance - In response to rumors suggesting that its high-caffeine drinks are akin to drugs, Bawang Chaji announced that its legal department is taking action against the spread of false information that harms its reputation [2]. - As of September 30, Bawang Chaji reported a total of 7,338 global stores, with a total GMV of 7.93 billion yuan and net revenue of 3.21 billion yuan for the third quarter [2].
霸王茶姬美股大跌!公司深夜回应
Zheng Quan Shi Bao·2025-12-27 01:40